Categories:

Affiliates:

Sponsored Links

Bladder cancer Research data :superficial bladder cancer

Bladder cancer treatment Research :superficial bladder cancer

Thailand Gift Shop

US 9.95 $

Thailand, Rayong's Sea animal Resin Key Chain(Star)

(Profit 10% give for Thai's cancer patient)

US 9.95 $

Thailand, Rayong's Sea animal Resin Key Chain(Star)

(Profit 10% give for Thai's cancer patient)

US 9.95 $

Thailand, Rayong's Sea animal Resin Key Chain(circle)

(Profit 10% give for Thai's cancer patient)

View Cart

John Theurer Cancer Center plays major role in FDA's fast tracking of ipilimumab for metastatic melanoma
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 ...

Bioniche reduces net loss per share from $0.15 in fiscal 2009 to $0.02 in fiscal 2010
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.

Rosetta Genomics Unveils Two New Development-Stage Tests
Rosetta Genomics this week unveiled two new microRNA-based tests under development, one a kidney cancer diagnostic and the other a mesothelioma prognosis assay, and disclosed that it will be building up an in-house sales force to market them and certain of its other second-generation products.

Onyx enters commercialization agreement with Ono for carfilzomib and ONX 0912 development program
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.

Press Release
Tikcro Technologies Ltd. Posted on:07 Sep 10 Tikcro Technologies Ltd. (OTC BB: TIKRF) today reported results for the second quarter and six months ended June 30, 2010.

Tikcro reports $3.2 million net loss for second-quarter 2010
Tikcro Technologies Ltd. today reported results for the second quarter and six months ended June 30, 2010.

Tikcro Technologies Reports 2010 Second Quarter Results
TEL AVIV, Israel--(BUSINESS WIRE)--Tikcro Technologies Ltd. (OTC BB: TIKRF) today reported results for the second quarter and six months ended June 30, 2010. Net loss for the second quarter was $3.2 million or $(0.38) per diluted share. Results for the second quarter included financial expenses of approximately $3.2 million that resulted from the valuation of Tikcro's holdings in BioCancell ...

Eight signs of cancer
Scientists have identified eight key signs of cancer which should be investigated immediately.

FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment
Celsion Corporation, a leading oncology drug development company, today announced that the U.S. Food and Drug Administration has designated the HEAT Study of its investigational drug, ThermoDox, in combination with radiofrequency ablation, as a Fast Track Development Program.

Daily Intake of "Yakult" Is Efficacious in Reducing Incidence of Acute Diarrhea in Young Children
Collaborative Study with India National Institute of Cholera and Enteric Diseases- YAKULT HONSHA CO., LTD. announced on August 20 that its collaborative study on the incidence of acute diar





Report: Al Qaeda still threat to America
Nearly nine years after the September 11, 2001, terror attacks, Americans still face a serious threat from al Qaeda, according to a new report from a panel of top national security experts.

U.N. resolution paves the way for Serbia-Kosovo talks
The U.N. General Assembly has adopted a landmark resolution calling for talks between Serbia and Kosovo, which declared its independence in February 2008.

Parents try to recover runaway teen in Brazil
An American family is desperately trying to get their daughter back after the 15-year-old ran away with her boyfriend to Brazil, where authorities handed her over to the boyfriend's family.

Japan may get new prime minister next week
The wife of Japan's prime minister is a pragmatist. When her husband, Naoto Kan, became prime minister in June, they moved in only with their summer clothes, she told a Japanese weekly magazine.

India revives British-era caste count
India plans to hold a full count of its citizens and their castes, the country's first since 1931.

Can tennis pair pave way to India-Pakistan harmony?
When Rohan Bopanna and Aisam-ul-Haq Qureshi step out on court for the U.S. Open men's doubles final on Friday night, there will be more than just sporting glory at stake.

Quran controversy casts pall over Eid celebrations
This Friday, Muslims around the world will bid goodbye to a long month of fasting with three days of feasting and festivities.

Bodies of Americans arrive home from Iraq
Like so many U.S. service members before them, the bodies of Sgt. Phillip Jenkins and Pvt. James McClamrock returned late Thursday to Dover Air Force Base in Delaware -- the most recent deaths of the war in Iraq.

Japan alarmed over China's yen purchases
Read full story for latest details.

Iran to release American hiker Sarah Shourd
Iran says it will release one of the three American hikers detained for more than a year on Saturday, a day after the conclusion of the Islamic holy month of Ramadan, according to an official at the ministry of culture and Islamic guidance.

Send To Friend

Send this link to a friend.

Friend's name:
Friend's email:

	Advances in the Treatment of Superficial Bladder Cancer: Optimizing Bcg Immunotherapy : Proceedings of a Symposium Held at the 23rd World Congress O (European Urology) by: Donald L. Lamm publisher: S. Karger AG (Switzerland), released: January, 1995 price:
	BCG in superficial bladder cancer: Proceedings of an EORTC Genitourinary Group sponsored meeting held at Erenstein Castle Kerkrade, the Netherlands, on ... in clinical and biological research) publisher: A.R. Liss, released: 1989 price: $1.53 (used)
	Bcg: The Optimal Approach in Superficial Bladder Cancer (European Urology) by: A. Bohle publisher: Not Avail, released: November, 1999 price: $25.25 (new)
	Eortc Genitourinary Group Monograph, No. 6: Bcg in Superficial Bladder Cancer by: F. M. J. Debruyne publisher: John Wiley & Sons, released: May, 2000 price: $73.35 (used)
	Superficial Bladder Cancer by: William R Fair publisher: Taylor & Francis, released: 01 April, 1997 price: $135.00 (new), $24.69 (used)